Inventor · disambiguated record
Yael Marantz
Also filed as: MARANTZ YAEL
18 granted patents·12 pending applications·148 citations·filing 2003–2015
94Inventor score
Top patents by PatentIndex Score
30 records- 0188US7919519B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2007·Granted Apr 5, 2011·14 cites·8 claims
- 0287US7153858B2Arylpiperazinyl compoundsEPIX DELAWARE INC·Filed 2004·Granted Dec 26, 2006·27 cites·57 claims
- 0386US7968538B2Substituted arylamine compounds and methods of treatmentGALENEA CORP·Filed 2006·Granted Jun 28, 2011·17 cites·60 claims
- 0484US7576211B2Synthesis of thienopyridinone compounds and related intermediatesEPIX DELAWARE INC·Filed 2005·Granted Aug 18, 2009·5 cites·2 claims
- 0583US7598265B2Compositions and methods for treating CNS disordersEPIX DELAWARE INC·Filed 2005·Granted Oct 6, 2009·7 cites·25 claims
- 0683US7030240B2Piperidinylamino-thieno[2,3-d] pyrimidine compoundsPREDIX PHARMACEUTICALS HOLDING·Filed 2004·Granted Apr 18, 2006·34 cites·22 claims
- 0782US7982040B2Thienopyridinone compounds and methods of treatmentNANOTHERAPEUTICS INC·Filed 2008·Granted Jul 19, 2011·5 cites·16 claims
- 0879US7488731B2Arylpiperazinyl compoundsEPIX DELAWARE INC·Filed 2007·Granted Feb 10, 2009·3 cites·9 claims
- 0979US7488736B2Thienopyridinone compounds and methods of treatmentEPIX DELAWARE INC·Filed 2004·Granted Feb 10, 2009·11 cites·16 claims
- 1078US7407966B2Thienopyridinone compounds and methods of treatmentEPIX DELAWARE INC·Filed 2004·Granted Aug 5, 2008·12 cites·13 claims
- 1177US7855193B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2006·Granted Dec 21, 2010·3 cites·11 claims
- 1276US7790707B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2007·Granted Sep 7, 2010·2 cites·11 claims
- 1374US7612078B2Piperidinylamino-thieno[2,3-D] pyrimidine compoundsEPIX DELAWARE INC·Filed 2005·Granted Nov 3, 2009·2 cites·16 claims
- 1472US8569259B2Adenosine analogs and their useBEN-ZEEV EFRAT·Filed 2007·Granted Oct 29, 2013·2 cites·21 claims
- 1572US7491727B2Arylpiperazinyl compoundsEPIX DELAWARE INC·Filed 2006·Granted Feb 17, 2009·1 cites·8 claims
- 1671US8604021B2Substituted arylamine compounds and methods of treatmentBECKER OREN·Filed 2011·Granted Dec 10, 2013·3 cites·15 claims
- 1759US2011195953A1Compositions and methods for treating cns disordersEPIX DELAWARE INC·Filed 2009·Application pending·0 cites
- 1858US9255121B2Adenosine analogs and their useMICRODOSE THERAPEUTX INC·Filed 2013·Granted Feb 9, 2016·0 cites·16 claims
- 1958US2010113485A1Piperidinylamino-thieno[2,3-D] Pyrimidine CompoundsDHANOA DALE S·Filed 2009·Application pending·0 cites
- 2050US2005222175A1New piperidinylamino-thieno[2,3-D] pyrimidine compoundsDHANOA DALE S·Filed 2004·Application pending·0 cites
- 2148US2016129036A1Adenosine analogs and their useMICRODOSE THERAPEUTX INC·Filed 2015·Application pending·0 cites
- 2248US2010331298A1Carboxamide Compounds and Their UseCYTOPATHFINDER INC·Filed 2008·Application pending·0 cites
- 2346US8569282B2Carboxamide compounds and their useBEN-ZEEV EFRAT·Filed 2008·Granted Oct 29, 2013·0 cites·35 claims
- 2446US2010210633A1Carboxamide compounds and their useEPIX DELAWARE INC·Filed 2007·Application pending·0 cites
- 2546US2010184749A1Benzothiadiazine compounds and their useEPIX DELAWARE INC·Filed 2007·Application pending·0 cites
- 2644US2010317649A1S1P Receptor Modulating Compounds and Use ThereofEPIX PHARM INC·Filed 2010·Application pending·0 cites
- 2744US2011212940A1S1P Receptor Modulating Compounds and Use ThereofEPIX PHARM INC·Filed 2011·Application pending·0 cites
- 2843US2011059945A1S1P Receptor Modulating Compounds and Use ThereofEPIX PHARM INC·Filed 2010·Application pending·0 cites
- 2940US2011082157A1Piperidinylamino-Thieno [2,3-D] Pyrimidine CompoundsDHANOA DALE S·Filed 2010·Application pending·0 cites
- 3040US2004138238A1Substituted aminopyrimidine compounds as neurokinin antagonistsFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yael Marantz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →